JUBLIA
Google image searchProduct monograph
Active ingredient
efinaconazole, 10 %/W/W
DIN: 02413388
Dosage form(s): SOLUTION
Route(s) of administration: TOPICAL
Schedule: Prescription
Company: BAUSCH HEALTH, CANADA INC.
Date: 21-JAN-2020
ATC:
- D01 — ANTIFUNGALS FOR DERMATOLOGICAL USE (ATC, ATC/DDD, )
- D01A — ANTIFUNGALS FOR TOPICAL USE (ATC, ATC/DDD)
- D01AC — Imidazole and triazole derivatives (ATC, ATC/DDD)
- D01AC19 — EFINACONAZOLE (ATC/DDD)
Reference brand drug: Jublia
